Neuberger Berman Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-5,806
Closed -$274K 1898
2022
Q3
$274K Sell
5,806
-3,792
-40% -$245K ﹤0.01% 1637
2022
Q2
$688K Buy
9,598
+3,156
+49% +$231K ﹤0.01% 1403
2022
Q1
$522K Sell
6,442
-947
-13% -$80.1K ﹤0.01% 1531
2021
Q4
$723K Buy
7,389
+1,639
+29% +$157K ﹤0.01% 1446
2021
Q3
$473K Buy
5,750
+107
+2% +$9.69K ﹤0.01% 1482
2021
Q2
$474K Buy
5,643
+152
+3% +$12.8K ﹤0.01% 1493
2021
Q1
$391K Sell
5,491
-201
-4% -$15.2K ﹤0.01% 1540
2020
Q4
$388K Buy
+5,692
New +$355K ﹤0.01% 1455
2016
Q2
Sell
-11,022
Closed -$454K 1590
2016
Q1
$454K Buy
11,022
+2,284
+26% +$94.1K ﹤0.01% 1282
2015
Q4
$424K Buy
+8,738
New +$389K ﹤0.01% 1315

Other funds holding SYNH

Neuberger Berman Group's SYNH Position: Q4 2022 in Review

Neuberger Berman Group sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 5,806 shares — an estimated $274K sold.

Neuberger Berman Group first reported a position in SYNH in Q4 2015 and held it in 10 quarters. The position peaked at $723K in Q4 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • Neuberger Berman Group reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Neuberger Berman Group sold 5,806 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $274K.
  • Neuberger Berman Group first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2015 and held it in 10 quarters.
  • Neuberger Berman Group's Syneos Health, Inc. Class A Common Stock position peaked at $723K in Q4 2021.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Neuberger Berman Group's 13F filing for Q4 2022, filed 13 Feb 2023.